As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another ...

Five-year-olds can be goofy. That was my first thought several years ago when my son stumbled and fell to the ground. But when he failed to get up and told ...